Skip to main content

Table 1 Distribution of Demographics Grouped by 25(OH)D Quartile

From: Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer

  Vitamin D Quartile
<20 ng/mL 20–39 ng/mL 40–59 ng/mL 60 + ng/mL Total 25(OH)D  
Characteristic No. patients (%) No. patients (%) No. patients (%) No. patients (%) No. patients (%) Avg. ng/mL (SD) P-value
Gender        
 Male 105 (56) 167 (56) 63 (52) 7 (32) 342 (55) 28 (±14) 0.15
 Female 83 (44) 129 (44) 58 (48) 15 (68) 285 (45) 30 (±17)
Ethnicity        <0.0001
 Caucasian 118 (25) 236 (50) 106 (22) 16 (3) 476 (76) 31 (±15)
 African American 57 (53) 36 (34) 11 (10) 3 (3) 107 (17) 22 (±15)
 Hispanic 0 (0) 7 (44) 0 (0) 1 (6) 16 (3) 22 (±14)
 Asian 0 (0) 4 (100) 0 (0) 0 (0) 4 (0.6) 30 (±6)
 Polynesian 0 (0) 0 (0) 1 (100) 0 (0) 1 (0.2) 48 (±0)
 Other* 5 (22) 5 (22) 3 (13) 2 (9) 23 (4) 30 (±16)
Cancer Stage        0.36
 1B 4 (50) 2 (25) 2 (25) 0 (0) 8 (1) 23 (±14)
 2A 13 (48) 9 (33) 4 (4) 1 (4) 27 (4) 24 (±16)
 2B 15 (31) 27 (56) 3 (6) 3 (6) 48 (8) 27 (±14)
 3 24 (28) 40 (47) 19 (22) 3 (3) 86 (14) 30 (±15)
 4 131(29) 216 (48) 92 (20) 15 (3) 454 (72) 29 (±16)
 Non-staged 1 (25) 2 (50) 1 (25) 0 (0) 4 (1) 28 (±11)
BMI (kg/m2)        0.05
  < 18.5 7 (27) 8 (31) 9 (35) 2 (8) 26 (4) 35 (±19)
 18.5–24.9 67 (25) 126 (48) 57 (22) 14 (5) 264 (42) 31 (±17)
 25–29.9 74 (36) 98 (47) 33 (16) 2 (1) 207 (33) 26 (±13)
 30+ 40 (31) 64 (49) 22 (17) 4 (3) 130 (21) 28 (±14)
  1. *Other ethnicities are patients who did not identify with any ethnicity listed above